Expression of Human Squamous Cell Differentiation Marker, SPR1, in Tracheobronchial Epithelium Depends on JUN and TRE Motifs (*)

  1. Sekhar P. M. Reddy(1)(§),
  2. Yue-Jen Chuu(1)(§)(¶),
  3. Paul N. Lao(2),
  4. Jerry Donn(1),
  5. David K. Ann(3) and
  6. Reen Wu(1)(2)(**)
  1. From the (1) California Regional Primate Research Center,
  2. (2) Department of Internal Medicine, School of Medicine, University of California at Davis, Davis, California 95616, and
  3. (3) Department of Molecular Pharmacology and Toxicology, University of Southern California, Los Angeles, California 90033
  1. ** To whom all correspondence should be addressed. Tel.: 916-752-2648; Fax: 916-752-2880.
  • Present address: Biological Dosimetry Group, Lawrence Livermore National Laboratory, Livermore, CA 94551.

Abstract

Tracheobronchial epithelial (TBE) cells that normally do not express the squamous cell differentiation marker gene, SPR1, can be induced to produce it by 12-O-tetradecanoylphorbol-13-acetate (TPA). The regulation of SPR1 gene expression by TPA occurs, in part, at the transcriptional level in primary human and monkey TBE cells. Using a transient transfection assay, we observed that TPA stimulates the activity of the reporter gene, chloramphenicol acetyltransferase, by 2-4-fold in transfected TBE cells. However, this chloramphenicol acetyltransferase activity is cell type-specific with significantly less activity in transformed epithelial cell lines and no activity in non-epithelial cell types. TPA-dependent stimulation can also be demonstrated by cotransfection with plasmid DNAs that overexpress the JUN family of proteins, especially c-JUN. Overexpression of c-JUN and TPA treatment synergistically stimulate the SPR1 promoter activity by more than 40-fold. Deletion analysis of the promoter region demonstrates that the DNA fragment of the first 98 base pairs of the 5′-flanking region contains the basal promoter activity, while the region between −162 and −96 contains the cis-enhancer elements for both the basal and TPA/c-JUN-stimulating promoter activities. This observation is supported by in vivo genomic footprinting studies that reveal persistent protections in the following motifs of this region: −141 TRE, −131 GT, −123 ETS-like, and −111 TRE-like motifs and in the enhanced protections in −141 TRE and −111 TRE-like motifs in cells after the TPA treatment. Site-directed mutagenesis in this region demonstrates the involvement of both −141 TRE and −111 TRE-like motifs in TPA/c-JUN-dependent stimulation as well as enhanced basal transcriptional activity. However, it is primarily the −111 TRE-like motif that is involved in the mediation of the enhanced basal promoter activity of the human SPR1 gene. These results are further supported by gel mobility shift assays that demonstrate the involvement of c-JUN and these TRE motifs in the formation of the DNA-protein complex.

Footnotes

  • § Contributed equally to this paper.

  • * Supported in part by National Institutes of Health Grants DE10742, HL35635, ES06230, and ES06553 and California Tobacco-related Disease Research Program Grant 3RT-0409. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

  • 1 The abbreviations used are:

    SPR

    small proline-rich protein

    TPA

    12-O-tetradecanoylphorbol-13-acetate

    TBE

    tracheobronchial epithelium

    TRE

    TPA-responsive element

    CRE

    cAMP-responsive element

    tk

    thymidine kinase

    CAT

    chloramphenicol acetyltransferase

    DMS

    dimethyl sulfate

    GT

    GGTGG motif

    ETS

    E-26 transformation specific

    HSV

    herpes simplex virus

    PCR

    polymerase chain reaction.

    • Received June 2, 1995.
    • Revision received August 31, 1995.
« Previous | Next Article »Table of Contents
  • Advertisement
  • Advertisement
Advertisement